• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • L. E. Asser, Ségolène Hescot, Say Viengchareun, Brigitte Delemer, Marc Lombès
  • Biology, Medicine
  • Molecular and Cellular Endocrinology
  • 2014 (First Publication: 1 September 2014)
  • Glucocorticoid receptor (GR), a ubiquitous transcriptional factor, regulates target gene expression upon activation by glucocorticoids, notably cortisol, a corticosteroid hormone synthesized in theExpand
  • Pierre-Yves Benhamou, Sylvia Franc, +23 authors Guillaume Charpentier
  • Medicine
  • 2019 (First Publication: 1 May 2019)
  • Summary Background Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1)Expand
  • Vincent Amodru, Patrick Petrossians, +13 authors Thomas Cuny
  • Medicine
  • Journal of the Endocrine Society
  • 2020 (First Publication: 8 May 2020)
  • Abstract Introduction: Acromegaly is a rare disease due to growth hormone (GH)-secreting pituitary adenoma. GH and IGF-1 levels are usually congruent, indicating either remission or active disease,Expand
  • Linda Humbert, Sylvain Dubucquoi, +18 authors Emmanuelle Proust Lemoine
  • Medicine
  • Journal of the Endocrine Society
  • 2019 (First Publication: 15 April 2019)
  • Abstract Background: APECED syndrome is a rare monogenic disease caused by homozygous mutation of AIRE gene. It classically presents with chronic mucocutaneous candidiasis, hypoparathyroidism, andExpand
  • Lucie Allard, Frédérique Albarel Loy, +11 authors Philippe Chanson
  • Medicine
  • Journal of the Endocrine Society
  • 2019 (First Publication: 15 April 2019)
  • Abstract Dopamine agonists (DAs), which are used as first line therapy in patients with macroprolactinomas, and antipsychotics have opposite effects on D2 dopamine receptors. In patients with severeExpand